Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
| 3be2 | RAJ | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.609 | |
| 4equ | G6I | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.596 | |
| 2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.570 | |
| 4bkj | STI | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.565 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.560 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.558 | |
| 2rl5 | 2RL | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.547 | |
| 2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.526 | |
| 3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.521 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.520 | |
| 4v01 | 0LI | Fibroblast growth factor receptor 1 (Fms-related tyrosine kinase 2, Pfeiffer syndrome), isoform CRA_b | / | 0.519 | |
| 2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.518 | |
| 3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.517 | |
| 3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.515 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.512 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.510 | |
| 3rfm | CFF | Adenosine receptor A2a | / | 0.510 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.509 | |
| 3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.508 | |
| 2bak | AQZ | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 4a9y | AQZ | Mitogen-activated protein kinase 14 | / | 0.506 | |
| 4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.506 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.504 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.504 | |
| 2gqg | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.502 | |
| 2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.501 | |
| 3t8x | T8X | T-cell surface glycoprotein CD1b | / | 0.501 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.500 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.497 | |
| 2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.497 | |
| 2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.496 | |
| 2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.495 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.495 | |
| 3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.494 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.494 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.493 | |
| 1xds | DRA | Aclacinomycin 10-hydroxylase RdmB | 4.1.1 | 0.493 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.493 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.492 | |
| 3tvx | PNX | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 3.1.4.53 | 0.491 | |
| 4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.491 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
| 1o6r | R19 | Squalene--hopene cyclase | 4.2.1.129 | 0.489 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.488 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.488 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.487 | |
| 1so2 | 666 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.486 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.486 | |
| 4uxq | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.486 | |
| 1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.485 | |
| 2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.485 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.485 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.484 | |
| 1m52 | P17 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.482 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.482 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.482 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.481 | |
| 4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.481 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.481 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.480 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.480 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.479 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.479 | |
| 2y1o | T26 | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.478 | |
| 4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.478 | |
| 2f4j | VX6 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.477 | |
| 4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.477 | |
| 4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.477 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.477 | |
| 1xuo | LA1 | Integrin alpha-L | / | 0.476 | |
| 3el7 | PD3 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
| 3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.476 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.476 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.476 | |
| 1xom | CIO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.475 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.475 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.475 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.475 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.475 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.473 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.473 | |
| 3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.473 | |
| 3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.473 | |
| 2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.472 | |
| 3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.472 | |
| 3zia | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.472 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.472 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.471 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.471 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.470 | |
| 2h42 | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.470 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.470 | |
| 3oq1 | 3OQ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.470 | |
| 4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.470 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.470 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.470 | |
| 1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.469 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.469 | |
| 3dh7 | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.468 | |
| 3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.468 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.468 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.467 | |
| 2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.467 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.467 | |
| 4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.467 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.467 | |
| 3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.466 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.466 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.466 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.466 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.465 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
| 3p3z | P3Z | Putative cytochrome P450 | / | 0.465 | |
| 3p9t | TCL | Repressor | / | 0.465 | |
| 4gkh | 0J9 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.465 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.465 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.465 | |
| 1zg3 | 2HI | Isoflavone 4'-O-methyltransferase | / | 0.464 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.464 | |
| 3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.464 | |
| 4rh1 | 0TT | Spore photoproduct lyase | / | 0.464 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.464 | |
| 1e6e | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.463 | |
| 2dqs | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.463 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
| 4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.463 | |
| 1y2c | 3DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.462 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.462 | |
| 3aba | FLI | Cytochrome P450 | / | 0.462 | |
| 3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
| 3o56 | ZG1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.462 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.462 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.462 | |
| 4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.462 | |
| 2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
| 3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.461 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.461 | |
| 1b87 | ACO | Aac(6')-Ii protein | / | 0.460 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
| 1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
| 1v7a | FRC | Adenosine deaminase | 3.5.4.4 | 0.460 | |
| 2hb8 | MVD | Vitamin D3 receptor | / | 0.460 | |
| 2p1u | 4TN | Retinoic acid receptor RXR-alpha | / | 0.460 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.460 | |
| 4fcb | 0T7 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
| 4ia7 | BIV | Vitamin D3 receptor A | / | 0.460 | |
| 4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.460 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.459 | |
| 2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.459 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.459 | |
| 3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
| 3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.459 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.459 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.459 | |
| 4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.459 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.459 | |
| 4k4j | 1O8 | Retinoic acid receptor RXR-alpha | / | 0.459 | |
| 2nr4 | FMN | Conserved protein | / | 0.458 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.458 | |
| 4b14 | 4XB | Glycylpeptide N-tetradecanoyltransferase | / | 0.458 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.458 | |
| 1e79 | ADP | ATP synthase subunit alpha, mitochondrial | / | 0.457 | |
| 1e79 | ADP | ATP synthase subunit beta, mitochondrial | 3.6.3.14 | 0.457 | |
| 1tg5 | 645 | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.457 | |
| 1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.457 | |
| 3d5w | ADP | Serine/threonine-protein kinase PLK | / | 0.457 | |
| 3dko | IHZ | Ephrin type-A receptor 7 | 2.7.10.1 | 0.457 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.457 | |
| 3hz5 | Z64 | Heat shock protein HSP 90-alpha | / | 0.457 | |
| 3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.457 | |
| 4fex | 0TO | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.457 | |
| 4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.457 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.457 | |
| 1ie4 | T44 | Transthyretin | / | 0.456 | |
| 1zdw | FLV | Prenyltransferase | / | 0.456 | |
| 2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.456 | |
| 2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.456 | |
| 2ykc | YKC | Heat shock protein HSP 90-alpha | / | 0.456 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.456 | |
| 3d4b | DZD | NAD-dependent protein deacetylase | / | 0.456 | |
| 3x0a | 5GP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.456 | |
| 4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.456 | |
| 4ea1 | 3RX | Dehydrosqualene synthase | / | 0.456 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.456 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.456 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.456 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.456 | |
| 1l2j | ETC | Estrogen receptor beta | / | 0.455 | |
| 1s3w | TQT | Dihydrofolate reductase | 1.5.1.3 | 0.455 | |
| 1soj | IBM | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 3.1.4.17 | 0.455 | |
| 1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.455 | |
| 3ar5 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.455 | |
| 3da2 | 4MD | Carbonic anhydrase 13 | 4.2.1.1 | 0.455 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.455 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.455 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.455 | |
| 1k74 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.454 | |
| 3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.454 | |
| 3tda | PN0 | Cytochrome P450 2D6 | / | 0.454 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.453 | |
| 2wes | FAD | Tryptophan 5-halogenase | / | 0.453 | |
| 2xnm | WGZ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.453 | |
| 2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.453 | |
| 3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.453 | |
| 3d74 | NBB | Pheromone-binding protein ASP1 | / | 0.453 | |
| 3jwm | 5WB | Dihydrofolate reductase | / | 0.453 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.453 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.453 | |
| 4lxh | C1E | Alpha/beta hydrolase fold | / | 0.453 | |
| 4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.453 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.453 | |
| 1y6b | AAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 2g2f | AGS | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.452 | |
| 2i0v | 6C3 | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.452 | |
| 2yhu | WHF | Pteridine reductase | / | 0.452 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.452 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.452 | |
| 3zei | AWH | O-acetylserine sulfhydrylase | / | 0.452 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
| 2fm0 | M98 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
| 2h44 | 7CA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.451 | |
| 3qlw | N22 | Dihydrofolate reductase | 1.5.1.3 | 0.451 | |
| 4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
| 4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 1xdk | REA | Retinoic acid receptor beta | / | 0.450 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.450 | |
| 2iut | AGS | DNA translocase FtsK | / | 0.450 | |
| 2y98 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.450 | |
| 2ydo | ADN | Adenosine receptor A2a | / | 0.450 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.450 | |
| 3lix | E17 | Protease | / | 0.450 | |
| 3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.450 | |
| 3v94 | WYQ | Phosphodiesterase | / | 0.450 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.450 | |
| 4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.450 | |
| 4qa0 | SHH | Histone deacetylase 8 | 3.5.1.98 | 0.450 | |
| 5dp2 | NAP | CurF | / | 0.450 | |
| 1f8g | NAD | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.449 | |
| 1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
| 1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.449 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.449 | |
| 1yho | TRR | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.449 | |
| 2fzi | DH3 | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.449 | |
| 2xls | FAD | Putative flavin-containing monooxygenase | / | 0.449 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.449 | |
| 3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
| 3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
| 4ixd | 1HV | Integrin alpha-L | / | 0.449 | |
| 2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.448 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.448 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.448 | |
| 3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.448 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.448 | |
| 4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.448 | |
| 4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
| 4fhf | 0TT | Spore photoproduct lyase | / | 0.448 | |
| 4iae | 1DX | Alr2278 protein | / | 0.448 | |
| 1fby | REA | Retinoic acid receptor RXR-alpha | / | 0.447 | |
| 1uhl | MEI | Retinoic acid receptor RXR-beta | / | 0.447 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.447 | |
| 2hcd | BIV | Vitamin D3 receptor A | / | 0.447 | |
| 2p15 | EZT | Estrogen receptor | / | 0.447 | |
| 2qk8 | MTX | Dihydrofolate reductase | / | 0.447 | |
| 2xnn | 430 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.447 | |
| 3czr | 3CZ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.447 | |
| 3d3p | 20A | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.447 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.447 | |
| 3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.447 | |
| 4bb3 | KKA | Isopenicillin N synthase | 1.21.3.1 | 0.447 | |
| 4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
| 4rbs | 0RV | Metallo-beta-lactamase type 2 | / | 0.447 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
| 3pwh | ZMA | Adenosine receptor A2a | / | 0.447 | |
| 2f98 | NGV | Aklanonic acid methyl ester cyclase AcmA | 5.5.1.23 | 0.446 | |
| 2g2h | P16 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 2pnu | ENM | Androgen receptor | / | 0.446 | |
| 2xke | WI2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.446 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
| 3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.446 | |
| 3iak | EV1 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
| 3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.446 | |
| 3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
| 4elb | 34R | Dihydrofolate reductase | / | 0.446 | |
| 4gki | 0JN | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.446 | |
| 4pkl | 1GH | Uncharacterized protein | / | 0.446 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
| 4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 1blz | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
| 1e1n | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.445 | |
| 1zkl | IBM | High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 3.1.4.53 | 0.445 | |
| 2hyd | ADP | Putative multidrug export ATP-binding/permease protein SAV1866 | 3.6.3 | 0.445 | |
| 2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.445 | |
| 2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
| 2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.445 | |
| 2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.445 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.445 | |
| 3dyl | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.445 | |
| 3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
| 3t14 | FAD | Sulfide-quinone reductase | / | 0.445 | |
| 3tgu | WF3 | Cytochrome b | / | 0.445 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3uvv | REA | Retinoic acid receptor RXR-alpha | / | 0.445 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
| 4kln | AGS | Transitional endoplasmic reticulum ATPase | 3.6.4.6 | 0.445 | |
| 4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
| 1eio | GCH | Gastrotropin | / | 0.444 | |
| 1syn | F89 | Thymidylate synthase | / | 0.444 | |
| 1ysx | 4EB | Serum albumin | / | 0.444 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 2osc | MUH | Angiopoietin-1 receptor | 2.7.10.1 | 0.444 | |
| 2zru | FMN | Isopentenyl-diphosphate delta-isomerase | / | 0.444 | |
| 3n5x | XFK | Nitric oxide synthase, brain | 1.14.13.39 | 0.444 | |
| 3p2o | NAD | Bifunctional protein FolD | / | 0.444 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.444 | |
| 4bub | ADP | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--LD-lysine ligase | / | 0.444 | |
| 1e1k | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.443 | |
| 1fm6 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.443 | |
| 1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.443 | |
| 2e99 | B08 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
| 2z3u | CRR | Cytochrome P450 | / | 0.443 | |
| 3dy8 | 5GP | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.443 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.443 | |
| 3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.443 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.443 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 4iah | 1DX | Alr2278 protein | / | 0.443 | |
| 4if5 | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.443 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
| 5doz | NDP | JamJ | / | 0.443 | |
| 1a8g | 2Z4 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 1fdu | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.442 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 2p1t | 3TN | Retinoic acid receptor RXR-alpha | / | 0.442 | |
| 2p1v | 5TN | Retinoic acid receptor RXR-alpha | / | 0.442 | |
| 3ac2 | KSE | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.442 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
| 3b9l | AZZ | Serum albumin | / | 0.442 | |
| 3h6k | 33T | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.442 | |
| 3oap | REA | Retinoic acid receptor RXR-alpha | / | 0.442 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 3qpo | PFR | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.442 | |
| 3wd7 | COA | Acridone synthase | / | 0.442 | |
| 3wix | LC3 | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.442 | |
| 4d7e | FAD | Putative lysine-N-oxygenase | / | 0.442 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.442 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.442 | |
| 1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.441 | |
| 2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.441 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.441 | |
| 3mb7 | 14I | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
| 3sgy | 06W | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4ele | 31I | Dihydrofolate reductase | / | 0.441 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 4gi2 | NAP | Crotonyl-CoA carboxylase/reductase | / | 0.441 | |
| 4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 4hfr | 14M | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 4ia2 | BIV | Vitamin D3 receptor A | / | 0.441 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.441 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.441 | |
| 2lbd | REA | Retinoic acid receptor gamma | / | 0.440 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 2uxx | FAJ | Lysine-specific histone demethylase 1A | 1 | 0.440 | |
| 2vcm | M11 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.440 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 3eel | 53T | Uncharacterized protein | / | 0.440 | |
| 3ha5 | SFG | Hydroxymycolate synthase MmaA4 | 2.1.1 | 0.440 | |
| 3iro | 2CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.440 | |
| 3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
| 3sh0 | SAX | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.440 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 4alh | A9P | Bromodomain-containing protein 2 | / | 0.440 | |
| 4dm6 | TTB | Retinoic acid receptor beta | / | 0.440 | |
| 4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.440 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.440 | |
| 4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.440 | |
| 4m8h | R4M | Retinoic acid receptor RXR-alpha | / | 0.440 | |
| 4ruo | BIV | Vitamin D3 receptor A | / | 0.440 | |
| 4rup | H97 | Vitamin D3 receptor A | / | 0.440 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.440 |